1. Current and emerging therapies for patients with advanced pancreatic ductal adenocarcinoma: a bright future. Issue 3 (March 2020) Authors: Christenson, Eric S; Jaffee, Elizabeth; Azad, Nilofer S Journal: Lancet oncology Issue: Volume 21:Issue 3(2020) Page Start: e135 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 529 Cancer cells educate natural killer cells to a metastasis promoting cell state. (10th December 2020) Authors: Chan, Isaac; Knútsdóttir, Hildur; Ramakrishnan, Gayathri; Padmanaban, Veena; Warrier, Manisha; Ramirez, Juan Carlos; Bader, Joel; Jaffee, Elizabeth; Ewald, Andrew Journal: Journal for immunotherapy of cancer Issue: Volume 8(2020)Supplement 3 Page Start: A323 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. 529 Cancer cells educate natural killer cells to a metastasis promoting cell state. (9th November 2020) Authors: Chan, Isaac; Knútsdóttir, Hildur; Ramakrishnan, Gayathri; Padmanaban, Veena; Warrier, Manisha; Ramirez, Juan Carlos; Bader, Joel; Jaffee, Elizabeth; Ewald, Andrew Journal: Journal for immunotherapy of cancer Issue: Volume 8(2020)Supplement 3 Page Start: A565 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. 812 Urelumab (anti-CD137 agonist) in combination with vaccine and nivolumab treatments is safe and associated with pathologic response as neoadjuvant and adjuvant therapy for resectable pancreatic cancer. (9th November 2020) Authors: Zheng, Lei; Judkins, Carol; Hoare, Jessica; Klein, Rachel; Parkinson, Rose; Wang, Hao; Cao, Haihui; Durham, Jennifer; Purtell, Katrina; Jesus-Acosta, Ana De; Le, Dung; Narang, Amol; Anders, Robert; Burkhart, Richard; Burns, William; Wolfgang, Christopher; Thompson, Elizabeth; Laheru, Daniel; He, ... Journal: Journal for immunotherapy of cancer Issue: Volume 8(2020)Supplement 3 Page Start: A862 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. A Phase IIb, randomized, multicenter study of the efficacy of GVAX pancreas vaccine and CRS-207 compared to chemotherapy or to CRS-207 alone in adults with previously-treated metastatic pancreatic adenocarcinoma (eclipse study). (6th November 2014) Authors: Wang-Gillam, Andrea; Picozzi, Vincent; Crocenzi, Todd; Morse, Michael; Zeh, Herbert; Fine, Robert; Murphy, Aimee; Skoble, Justin; Lemmens, Edward; Ferber, Sandy; Rosen, Allan; Grous, John; Dubensky, Thomas W; Brockstedt, Dirk; Jaffee, Elizabeth; Le, Dung Journal: Journal for immunotherapy of cancer Issue: Volume 2(2014)Supplement 3 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Modified STING-activating cyclic dinucleotide derivatives significantly enhance the anti-tumor activity of therapeutic vaccines. (7th November 2013) Authors: Leong, Meredith; Kanne, David; Glickman, Laura; Lemmens, Edward; Lauer, Peter; Metchette, Ken; Burdette, Dara; Diner, Elie; Fu, Juan; Soares, Kevin; Brockstedt, Dirk; Portnoy, Daniel; Vance, Russell; Kim, Young; Jaffee, Elizabeth; Pardoll, Drew; Dubensky, Thomas Journal: Journal for immunotherapy of cancer Issue: Volume 1(2013)Supplement 1 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Development of mutome-specific personalized vaccines for pancreatic cancer. (7th November 2013) Authors: Lutz, Eric; Kinkead, Heather; Yager, Allison; Armstrong, Todd; Lauer, Peter; Brockstedt, Dirk; Dubensky, Thomas; Jaffee, Elizabeth Journal: Journal for immunotherapy of cancer Issue: Volume 1(2013)Supplement 1 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Current progress in immunotherapy for pancreatic cancer. Issue 1 (10th October 2016) Authors: Foley, Kelly; Kim, Victoria; Jaffee, Elizabeth; Zheng, Lei Journal: Cancer letters Issue: Volume 381:Issue 1(2016) Page Start: 244 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Randomized Phase II study of the safety, efficacy and immune response of GVAX pancreas (with cyclophosphamide) and CRS-207 with or without nivolumab in patients with previously treated metastatic pancreatic adenocarcinoma (STELLAR). Issue 2 (December 2015) Authors: Le, Dung; Crocenzi, Todd; Urum, Jennifer; Lutz, Eric; Laheru, Daniel; Sugar, Elizabeth; Vonderheide, Robert; Fisher, George; Ko, Andrew; Murphy, Aimee; McDougall, Katherine; Ferber, Sandy; Brockstedt, Dirk; Jaffee, Elizabeth Journal: Journal for immunotherapy of cancer Issue: Volume 3:Issue 2(2015) Page Start: 1 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Long term survivors and immune biomarker analysis of Phase IIa, randomized study of GVAX pancreas and crs-207 immunotherapy in patients with metastatic pancreatic cancer. Issue 2 (December 2015) Authors: Nair, Nitya; Lemmens, Ed; Enstrom, Amanda; Chen, Shih-Yu; Chang, Serena; Le, Dung; Jaffee, Elizabeth; Maecker, Holden; Murphy, Aimee; Brockstedt, Dirk; Whiting, Chan Journal: Journal for immunotherapy of cancer Issue: Volume 3:Issue 2(2015) Page Start: 1 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗